IL6 and capillary hemangioma: Moreover, expression levels of other proangiogenic factors, such as matrix metalloproteinase 1 and interleukin-6 were also were found to be suppressed in HemSCs after corticosteroid treatment (Greenberger et al., 2010b), indicating that HemSCs were the potential target for infantile hemangioma treatment.